Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes
暂无分享,去创建一个
Adrian F Hernandez | Eric E. Smith | DaiWai M Olson | Deepak L. Bhatt | Gregg C Fonarow | Deepak L Bhatt | Jeffrey L Saver | G. Fonarow | E. Peterson | L. Schwamm | J. Saver | Adrian F. Hernandez | M. Reeves | Maria V. Grau‐Sepulveda | Daiwai M. Olson | Mathew J Reeves | Eric D Peterson | Eric E Smith | Lee H Schwamm | Maria V Grau-Sepulveda | E. Smith
[1] Robert A. Zimmerman,et al. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. , 1990, Stroke.
[3] K. Lee. Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2010 .
[4] W. Heiss,et al. The Cologne Stroke Experience: Safety and Outcome in 450 Patients Treated with Intravenous Thrombolysis , 2007, Cerebrovascular Diseases.
[5] D. Fatovich,et al. Thrombolysis in acute ischaemic stroke , 2012, The Lancet.
[6] Li Liang,et al. Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009, Circulation.
[7] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[8] Jeffrey L Saver,et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. , 2009, Stroke.
[9] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[10] R E Latchaw,et al. Recommendations for the establishment of primary stroke centers , 2000 .
[11] Maarten Schrooten,et al. Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale , 2009, Stroke.
[12] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[13] J. Saver. Time Is Brain—Quantified , 2006, Stroke.
[14] M. Budoff,et al. National Institute of Neurological Disorders and Stroke , 2008 .
[15] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[16] L. Schwamm,et al. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. , 2008, Archives of internal medicine.
[17] K. Labresh,et al. Get with the guidelines. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[18] S. Y. Kim,et al. Pre‐hospital notification reduced the door‐to‐needle time for iv t‐PA in acute ischaemic stroke , 2009, European journal of neurology.
[19] Peter Moyer,et al. Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association’s Task Force on the Development of Stroke Systems , 2005, Circulation.
[20] L. Thomassen,et al. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre , 2009, Emergency Medicine Journal.
[21] G. Albers,et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. , 2000, JAMA.
[22] Werner Hacke,et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.
[23] M. Kaste,et al. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment , 2006, Neurology.
[24] J. Grotta,et al. Early stroke treatment associated with better outcome: the ninds rt-pa stroke study , 2000, Neurology.
[25] Gregory W Albers,et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.
[26] M. Schulzer,et al. Reduction in IV t-PA Door to Needle Times Using an Acute Stroke Triage Pathway , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.